1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine manufacturers
|
| | 1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine Basic information |
| Product Name: | 1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine | | Synonyms: | 1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine;1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-(b-D-xylofuranosyl)guanine;1H-Purine-6,8-dione, 1,2-diamino-7-(cyclopropylmethyl)-7,9-dihydro-9-β-D-xylofuranosyl-;1,2-diamino-7-(cyclopropylmethyl)-9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7,9-dihydro-1H-purine-6,8-dione | | CAS: | 2389988-22-9 | | MF: | C14H20N6O6 | | MW: | 368.35 | | EINECS: | | | Product Categories: | | | Mol File: | 2389988-22-9.mol |  |
| | 1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine Chemical Properties |
| Boiling point | 645.3±65.0 °C(Predicted) | | density | 2.20±0.1 g/cm3(Predicted) | | pka | 13.40±0.70(Predicted) |
| | 1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine Usage And Synthesis |
| Uses | 1-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 1-Amino-7-cyclopropylmethyl-7,8-dihydro-8-oxo-9-
(beta-D-xylofuranosyl)guanine Preparation Products And Raw materials |
|